MedTrace Logo

Cryoablation of Low Risk Small Breast Cancer- ICE3 Trial

NCT02200705 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 206

Last updated 2025-04-30

Study results available
· View outcomes & findings →

Summary

To evaluate the efficacy of cryoablation without lumpectomy and its impact on local and distant recurrence of early stage breast cancer .

Conditions

Interventions

DEVICE

Ice-Sense3TM/ ProSenseTM

Sponsors & Collaborators

  • IceCure Medical Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2024-03-17
Completion
2024-05-26
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02200705 on ClinicalTrials.gov